| [1] |
|
| [2] |
|
| [3] |
Attal N, Martinez V, Bouhassira D．Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic[J]. Pain Rep， 2021， 6(1):e884.DOI： 10.1097/PR9.0000000000000884.
|
| [4] |
Colloca L, Ludman T, Bouhassira D，et al.Neuropathic pain[J]. Nat Rev Dis Primers， 2017(3):17002.DOI： 10.1038/nrdp.2017.2.
|
| [5] |
Inoue K, Tsuda M. Microglia in neuropathic pain：cellular and molecular mechanisms and therapeutic potential[J]. Nat Rev Neurosci， 2018， 19(3):138-152.DOI： 10.1038/nrn.2018.2.
|
| [6] |
Sarlus H, Heneka MT.Microglia in Alzheimer's disease[J]. J Clin Invest， 2017， 127(9):3240-3249.DOI： 10.1172/JCI90606.
|
| [7] |
Orihuela R, McPherson CA, Harry GJ.Microglial M1/M2 polarization and metabolic states[J]. Br J Pharmacol， 2016， 173(4):649-665.DOI： 10.1111/bph.13139.
|
| [8] |
Nguyen HM, Grössinger EM, Horiuchi M，et al.Differential Kv1.3，KCa3.1，and Kir2.1 expression in " classically" and " alternatively" activated microglia[J]. Glia， 2017， 65(1):106-121.DOI： 10.1002/glia.23078.
|
| [9] |
Tang Y, Le W．Differential roles of M1 and M2 microglia in neurodegenerative diseases[J]. Mol Neurobiol， 2016， 53(2):1181-1194.DOI： 10.1007/s12035-014-9070-5.
|
| [10] |
Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration[J]. Annu Rev Immunol， 2017(35):441-468.DOI： 10.1146/annurev-immunol-051116-052358.
|
| [11] |
Correale J．The role of microglial activation in disease progression[J]. Mult Scler， 2014， 20(10):1288-1295.DOI： 10.1177/1352458514533230.
|
| [12] |
Mantovani A, Sica A, Sozzani S，et al.The chemokine system in diverse forms of macrophage activation and polarization[J]. Trends Immunol， 2004， 25(12):677-686.DOI： 10.1016/j.it.2004.09.015.
|
| [13] |
Du RH, Sun HB, Hu ZL，et al.Kir6.1/K-ATP channel modulates microglia phenotypes：implication in Parkinson's disease[J]. Cell Death Dis， 2018， 9(3):404.DOI： 10.1038/s41419-018-0437-9.
|
| [14] |
Song GJ, Suk K．Pharmacological modulation of functional phenotypes of microglia in neurodegenerative diseases[J]. Front Aging Neurosci， 201(9):139.DOI： 10.3389/fnagi.2017.00139.
|
| [15] |
Wang X, Jiang Y, Li J，et al.DUSP1 promotes microglial polarization toward M2 phenotype in the medial prefrontal cortex of neuropathic pain rats via inhibition of MAPK pathway[J]. ACS Chem Neurosci， 2021， 12(6):966-978.DOI： 10.1021/acschemneuro.0c00567.
|
| [16] |
Kong F, Sun K, Zhu J，et al.PD-L1 Improves motor function and alleviates neuropathic pain in male mice after spinal cord injury by inhibiting MAPK pathway[J]. Front Immunol， 2021(12):670646.DOI： 10.3389/fimmu.2021.670646.
|
| [17] |
Yuan J, Fei Y．Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization[J]. Open Med (Wars)， 2022， 17(1):897-906.DOI： 10.1515/med-2022-0480.
|
| [18] |
Zhang LQ, Gao SJ, Sun J，et al.DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation[J]. J Neuroinflammation， 2022， 19(1):129.DOI： 10.1186/s12974-022-02495-x.
|
| [19] |
Rismanbaf A, Afshari K, Ghasemi M，et al.Therapeutic effects of azithromycin on spinal cord injury in male wistar rats：a role for inflammatory pathways[J]. J Neurol Surg A Cent Eur Neurosurg， 2022， 83(5):411-419.DOI： 10.1055/s-0041-1735854.
|
| [20] |
Xue MT, Sheng WJ, Song X，et al.Atractylenolide III ameliorates spinal cord injury in rats by modulating microglial/macrophage polarization[J]. CNS Neurosci Ther， 2022， 28(7):1059-1071.DOI： 10.1111/cns.13839.
|
| [21] |
Xu F, Huang J, He Z, et al. Microglial polarization dynamics in dorsal spinal cord in the early stages following chronic sciatic nerve damage[J]. Neurosci Lett， 2016(617):6-13.DOI： 10.1016/j.neulet.2016.01.038.
|
| [22] |
Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord[J]. J Neurosci， 2009， 29(43):13435-13444.DOI： 10.1523/JNEUROSCI.3257-09.2009.
|
| [23] |
Willemen HL, Huo XJ, Mao-Ying QL，et al.MicroRNA-124 as a novel treatment for persistent hyperalgesia[J]. J Neuroinflammation， 2012(9):143.DOI： 10.1186/1742-2094-9-143.
|
| [24] |
Yang Z, Xu J, Zhu R, et al. Down-regulation of miRNA-128 contributes to neuropathic pain following spinal cord injury via activation of P38[J]. Med Sci Monit， 2017(23):405-411.DOI： 10.12659/msm.898788.
|
| [25] |
Zhang Y, Chen Q, Nai Y，et al.Suppression of miR-155 attenuates neuropathic pain by inducing an M1 to M2 switch in microglia[J]. Folia Neuropathol， 2020， 58(1):70-82.DOI： 10.5114/fn.2020.94008.
|
| [26] |
Chang S, Li X, Zheng Y，et al.Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF-κB signaling pathway[J]. Phytother Res， 2022， 36(4):1678-1691.DOI： 10.1002/ptr.7396.
|
| [27] |
|
| [28] |
Liu C, Sun Q, Xu J，et al.The role of bone morphogenetic protein 4 in microglial polarization in the process of neuropathic pain[J]. J Inflamm Res， 2022(15):2803-2817.DOI： 10.2147/JIR.S356531.
|
| [29] |
Jiang Y, Wang J, Li H，et al.IL-35 promotes microglial M2 polarization in a rat model of diabetic neuropathic pain[J]. Arch Biochem Biophys， 2020(685):108330.DOI： 10.1016/j.abb.2020.108330.
|